Diagnostics firm LumiraDx completes merger with CAHC
The merger that values LumiraDx at $3bn enables it to become publicly traded company
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
The merger that values LumiraDx at $3bn enables it to become publicly traded company
Featuring k-wireless percutaneous implant delivery with an all-in-one screw inserter, the MOSS VRS MIS system is developed to…
OmniGraf is claimed to be the only combination biomarker panel that offers the earliest indication of rejection in…
The Advantage-C device is developed for use in skeletally mature patients in levels C2-T1 in conjunction with fixation…
Relivion DP is a non-invasive and multi-channel brain neuromodulation system for at home treatment of neurological and neuropsychiatric…
Designed to run on cobas 6800/8800 systems, the three molecular PCR diagnostic test panels will facilitate the detection…
Paige Prostate software has the potential to detect an area of interest on the prostate biopsy image with…
Precision Coating offers medical coatings and application solutions, while N2 Biomedical provides nano-engineered surface treatment and coating services…
Dr Mark Tauber from Athos Klinik has performed the first anatomic total shoulder surgery in Europe using the…
The EUA facilitates to use of the instrument-free RT-PCR Covid-19 test for testing pooled patient samples in high-complexity…